FDA Drug Application (085883) for CAPITAL AND CODEINE by ACTAVIS MID ATLANTIC

Back to FDA Applications sponsored by ACTAVIS MID ATLANTIC

Application Number085883
Product Number001
FormSUSPENSION;ORAL
Dosage120MG/5ML;12MG/5ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCAPITAL AND CODEINE
Active IngredientACETAMINOPHEN; CODEINE PHOSPHATE

Active IngredientCount
List of drugs with Active Ingredient ACETAMINOPHEN107
List of drugs with Active Ingredient CODEINE PHOSPHATE51


Back to FDA Applications sponsored by ACTAVIS MID ATLANTIC